diltiazem has been researched along with Ear Diseases in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonaiuto, G; Cox, R; Naples, J; Parham, K | 1 |
Carnero-González, L; de Quintana-Sancho, A; Drake-Monfort, M; González-Pérez, R | 1 |
Naples, JG; Parham, K | 1 |
Safdarian, M | 1 |
Naples, J; Parham, K | 1 |
5 other study(ies) available for diltiazem and Ear Diseases
Article | Year |
---|---|
Prestin as an Otologic Biomarker of Cisplatin Ototoxicity in a Guinea Pig Model.
Topics: Animals; Biomarkers; Cisplatin; Diltiazem; Disease Models, Animal; Ear Diseases; Evoked Potentials, Auditory, Brain Stem; Female; Guinea Pigs; Proteins | 2018 |
Usefulness of 2% Topical Diltiazem in Chondrodermatitis Nodularis Helicis: A Report of 2 Cases.
Topics: Administration, Topical; Aged; Calcium Channel Blockers; Cartilage Diseases; Dermatitis; Diltiazem; Ear Auricle; Ear Diseases; Humans; Male; Middle Aged | 2019 |
Cisplatin-Induced Ototoxicity and the Effects of Intratympanic Diltiazem in a Mouse Model.
Topics: Animals; Antineoplastic Agents; Calcium Channel Blockers; Cisplatin; Diltiazem; Disease Models, Animal; Ear Diseases; Female; Injection, Intratympanic; Mice; Mice, Inbred CBA | 2016 |
A Revision in Evaluating the Results of Intratympanic Otoprotective Injections against Cisplatin-Induced Ototoxicity.
Topics: Animals; Antineoplastic Agents; Calcium Channel Blockers; Cisplatin; Diltiazem; Ear Diseases; Female | 2016 |
Response to "A Revision in Evaluating the Results of Intratympanic Otoprotective Injections against Cisplatin-Induced Ototoxicity".
Topics: Animals; Antineoplastic Agents; Calcium Channel Blockers; Cisplatin; Diltiazem; Ear Diseases; Female | 2016 |